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Abstract 
Loss of basal forebrain cholinergic neurons is an early and key feature of 
Alzheimer's disease. The aim of this study was to determine whether loss of 
basal forebrain cholinergic neurons underpins changes detected using diffusion 
magnetic resonance imaging (dMRI) and probabilistic tractography in a mouse 
model. The toxin saporin conjugated to a p75 neurotrophin receptor antibody 
(mu-p75-SAP) was used to induce a specific lesion of the basal forebrain 
cholinergic neurons (~30% loss) and significant loss of terminal cholinergic 
projections in the hippocampus in C57Bl/6J mice, as determined by histology. 
Analysis by dMRI of the basal forebrain revealed a significant increase in 
anisotropic diffusion parameters in lesioned mice compared with control (Rb-IgG-
SAP) animals. These parameters strongly inversely correlated with the number of 
choline acetyl transferase-positive neurons. Moreover, probabilistic tractography 
analysis of the septo-hippocampal tracts revealed a trend to significant change in 
diffusion parameters in lesioned mice. This study illustrates that moderate loss of 
basal forebrain cholinergic neurons (representing only a minor proportion of all 
septo-hippocampal axons in our case) can be detected by measuring diffusion 
parameters of either the basal forebrain nuclei or possibly the basal forebrain 
tracts, thereby further validating the feasibility of dMRI and probabilistic 
tractography as non-invasive tools for diagnosing Alzheimer's disease in humans. 
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1. Introduction 
The basal forebrain is a key modulator of neurotransmission, function and 
plasticity of the hippocampus and amygdala, as well as the entire cortical mantle 
(Mesulam et al., 1983), and is strongly implicated in regulating attention, learning 
and memory (Mufson, 2003). Loss of the cholinergic neurons of the basal 
forebrain is a pathological hallmark of Alzheimer’s disease at autopsy (Mufson et 
al., 2002; Whitehouse et al., 1982). Furthermore, numerous studies have shown 
that degeneration of the basal forebrain is linked, albeit indirectly, to early signs 
of cognitive decline in Alzheimer’s disease patients, including deficits in spatial 
navigation and memory (George et al., 2009; Grothe et al., 2011; Grothe et al., 
2010; Muth et al., 2010). In these studies, magnetic resonance imaging (MRI) 
methods were used to detect structural changes associated with atrophy of the 
basal forebrain, particularly in the posterior regions (Grothe et al., 2011), these 
changes being correlated with cognitive decline in clinical cohorts of patients 
diagnosed with Alzheimer’s disease or its prodromal stage, mild cognitive 
impairment (MCI). In some cases, basal forebrain atrophy was observed as early 
as 4.5 years before the onset of overt clinical symptoms (Hall et al., 2008). 
By the time atrophy of a structure can be detected as a volumetric reduction with 
structural MRI, significant cell and tissue loss has already occurred. The drugs 
currently prescribed for the treatment of Alzheimer's disease, inhibitors of acetyl 
cholinesterase, enhance basal forebrain cholinergic function by inhibiting the 
degradation of acetylcholine produced by the surviving neurons. However, as the 
diagnosis of MCI or Alzheimer's disease currently occurs at a stage at which the 
cholinergic system has been irreversibly damaged, it is not surprising that these 
drugs have mild to little effect in prolonging cognitive function (Mancuso et al., 
2011). Non-invasive early detection of basal forebrain neurodegeneration prior to 
overt tissue loss therefore has the potential to improve the window of efficacy of 
acetylcholine esterase inhibitors for the treatment of Alzheimer's disease. 
Diffusion MRI (dMRI) is a technique that can be used to analyze differences in 
structural integrity and brain connectivity, and has been successfully employed to 
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detect differences between Alzheimer’s patients and healthy control subjects 
(Kiuchi et al., 2009; Pievani et al., 2010; Teipel et al., 2010). dMRI measures 
water diffusion within a tissue, with common dMRI measures including fractional 
anisotropy (FA), a measure of the degree of diffusion anisotropy where a value of 
zero means that diffusion is unrestricted (or equally restricted) and a value of one 
means that diffusion only occurs along one axis and is fully restricted in all other 
directions, mean diffusivity, a measure describing the extent of free diffusion 
without assuming a particular direction, axial diffusivity (AD; also known as 
parallel diffusivity), a measure of the extent of water moving along the primary 
axis of diffusion, and radial diffusivity (RD; also known as perpendicular 
diffusivity), a measure of water movement along the minor axes perpendicular to 
the primary axis. These dMRI parameters can be extracted for individual brain 
regions as well as for streamlines generated from dMRI data by tractography, a 
technique that is used to infer the connectivity of the brain, particularly of white-
matter tracts (Mori and Zhang, 2006). 
Based on the idea that cholinergic axons become dystrophic prior to neuronal 
degeneration (Ypsilanti et al., 2008), the aim of the current study was to 
determine whether mild to moderate loss of basal forebrain cholinergic nuclei and 
axons could underpin changes to dMRI measures and tractography prior to the 
point at which changes correlate with overt atrophy. In order to investigate this, 
we used a mouse model in which the toxin saporin, conjugated to an antibody to 
a receptor almost exclusively expressed by basal forebrain cholinergic neurons 
(p75 neurotrophin receptor; p75NTR), is injected into the ventricles (Berger-
Sweeney et al., 2001). This treatment has been demonstrated to provide a robust 
model of the selective basal forebrain cholinergic neuron loss and behavioral 
consequences seen in Alzheimer’s disease (Berger-Sweeney et al., 2001; 
Kokjohn and Roher, 2009; Moreau et al., 2008; Nilsson et al., 1992; Perry et al., 
2001; Rossner, 1997).  We hypothesized that all dMRI measures of the basal 
forebrain nuclei, together with the diffusion measures but not track number per se 
of septo-hippocampal tractograms, would be altered to reflect the 
neurodegeneration induced by this model.  
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2. Materials and Methods 
2.1 Animals 
Experimentally naive male C57Bl/6J mice were housed in groups of four and 
maintained on a 12 h light/dark cycle, with food and water ad libitum. All 
procedures were approved by the University of Queensland Animal Ethics 
Committee. 
2.2 Surgery 
Eight 8-10 week old male C57Bl/6J mice (22-24g) were anesthetized by 
intraperitoneal (i.p.) injection with a mixture of ketamine (130 mg/kg) and the 
muscle relaxant xylazine (6 mg/kg). Each mouse was then placed in a 
stereotaxic frame (with the incisor bar maintained at -3.3 mm below horizontal to 
achieve a flat skull position). Bilateral infusions of mu-p75-saporin or control 
rabbit-IgG-saporin dissolved in phosphate buffered saline (PBS; 0.2 μg/ventricle; 
Advanced Targeting Systems, San Diego, CA) were performed using a 30G 
needle attached to a 5μl Hamilton syringe. The needle was lowered into the 
lateral ventricle using the following co-ordinates: A-P, -0.3 mm; M-L, 1.0 mm; D-
V, −2.0 mm from Bregma; (Franklin and Paxinos, 2007). Infusions were 
conducted over 5 min, after which the needle was left in place for 10 min to allow 
for diffusion. Immediately after surgery, mice were injected subcutaneously (s.c.) 
with the analgesic torbogesic (1.3 mg/kg), and the antibiotic Baytril® (0.43 mg/kg). 
Fourteen days post-surgery mice were deeply anesthetized with sodium 
pentobarbital (100 mg/kg i.p.) and perfused transcardially with 20 ml of 0.9% 
saline, containing 1% sodium nitrite and heparin (5000 I.U./ml), followed by 100 
ml of 4% paraformaldehyde in 0.1 M phosphate buffer (PB), pH 7.4. Brains were 
post-fixed overnight in the same fixative, followed by repeated washing in PBS 
(pH 7.4) for 4 days prior to MRI acquisition. 
2.3 MRI acquisition 
After perfusion, mouse brains were washed in PBS for 4 days, after which they 
were immersed in Fomblin oil (Y06/6 grade, Solvay, NY) and diffusion weighted 
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magnetic resonance images were acquired according to the protocol of Moldrich 
et al. (2010). Briefly, we used a small animal MRI system (16.4 T vertical bore; 
Bruker Biospin, Rheinstetten, Germany; ParaVision v5.0) with a 15 mm linear 
SAW coil (M2MImaging, Brisbane, Australia). 3D DWspin-echo sequences were 
acquired with TR/TE = 400ms/22.3 ms, NEX=1 and a signal average of 1. We 
acquired thirty high diffusion-weighted images (b=5000 s/mm2) as well as two low 
diffusion weighted (b=0 s/mm2) images for each mouse brain with encoding 
gradient (δ/Δ=25/14 ms) vectors uniformly distributed using the electrostatic 
approach (Jones et al., 1999). Resolution was set at 100 µm isotropic 
(uninterpolated) and total imaging time was 16 h. 
2.4 Basal forebrain mask 
Reconstruction was performed using MRtrix (v0.2.9, 
www.nitrc.org/projects/mrtrix). Regions of interest (ROIs) were drawn manually 
on 12 consecutive coronal slices using color-coded FA maps generated by 
diffusion tensor imaging (DTI) reconstruction of the diffusion data. Using the 
mouse brain atlas of Franklin and Paxinos (2007) as guidance, ROIs of the basal 
forebrain were drawn, starting with the second slice anterior to the first slice 
where the genu of the corpus callosum is connected through the midline 
(approximately 1.34 mm anterior to Bregma) and finishing before the anterior 
commissure crosses the midline (approximately 0.26 mm anterior to Bregma), 
thereby assuring that the mask predominately encompassed the medial septum 
and the vertical and horizontal diagonal bands of Broca. The anterior-posterior 
distance covered was 1200 μm (12 slices of 100 μm). The average size of the 
ROI did not differ significantly between the control and lesioned groups (see 
section 3.2). The basal forebrain mask was used to extract FA, mean diffusivity, 
axial diffusivity and radial diffusivity. 
2.5 Tractography 
MRtrix (v0.2.9, www.nitrc.org/projects/mrtrix) was used to perform constrained 
spherical deconvolution (CSD) and to generate the fiber orientation distribution 
(FOD). Probabilistic tractography was performed with MRtrix, creating whole 
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brain tractograms by seeding every voxel five times and using tracking 
parameters optimized for mouse brain (step size = 0.01 mm, curvature = 0.07 
mm, seeds/voxel = 5; (Moldrich et al., 2010). 
Basal forebrain streamlines were then extracted by applying the basal forebrain 
mask to the whole brain tractograms. To image streamlines that project from the 
basal forebrain through the fimbria/fornix to the hippocampus, but not including 
cortical areas, a hippocampal waypoint ROI was created at approximately -2.60 
mm posterior to Bregma. This hippocampal waypoint ROI, together with 
additional exclusions used in conjunction with the basal forebrain mask, 
eliminated false positive streamlines such as the stria terminalis and the optic 
tract. 
To test whether the streamline changes were selective for the basal forebrain 
tracts, we performed tractography on a control tract, the inferior cerebellar 
peduncle. Bilateral ROIs were drawn on color-coded FA maps on three 
consecutive slices from approximately -6.00 to -6.24 mm posterior to Bregma, 
using the mouse brain atlas of Franklin and Paxinos (2007) as guidance. Inferior 
cerebellar peduncle streamlines were obtained by applying the ROI to whole 
brain tractograms. 
The measure streamline number was normalized to the voxel number of the 
corresponding ROI. A threshold of 15 streamlines (determined empirically) was 
used to measure track volume. In addition, FA, mean diffusivity, axial diffusivity 
and radial diffusivity were extracted from the tracks using the individual tracks for 
sampling. 
2.6 Volumetric measurements 
The hippocampal volume was measured using itk-snap (www.itksnap.org) and 
normalized to the brain volume (excluding olfactory bulbs, cerebellum and 
brainstem, to avoid areas that possibly got damaged during brain removal). 
2.7 MRI data analysis 
An unpaired two-tailed non-parametric t-test (Mann-Whitney, CI = 95%) was 
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used to determine significant differences of means for basal forebrain mask and 
tractography diffusion measures. For correlations, a non-parametric correlation of 
regression (Spearman) analysis was used. False discovery rate (α = 0.1) was 
used to correct for multiple comparisons. 
2.8 Immunohistochemistry 
Immediately following scanning (see section 2.2) brains were placed in 20% 
sucrose solution overnight. Brains were blocked using a matrix (Stoelting Co., 
Wood Dale, IL), aligned to the atlas of Franklin and Paxinos (2007), and 40 µm 
coronal sections were cut in three serially adjacent sets through the basal 
forebrain and hippocampus using a sliding microtome (SM2000r, Leica, Sydney, 
Australia). Sections were stored in 0.1% sodium azide in 0.1 M PBS. 
One series of sections was used to reveal choline acetyltransferase (ChAT) 
using peroxidase immunohistochemistry. Free-floating sections were washed 
repeatedly in 0.1 M PB, followed by two 30 min washes in 50% ethanol, the 
second of which contained 3% H2O2. Sections were then incubated in 5% normal 
horse serum (NHS) in PB for 30 min, followed by incubation with goat anti-ChAT 
antibody (1:3000; Millipore, Billerica, MA), diluted in 0.1 M PB containing 0.1% 
sodium azide, 2% NHS and 0.2% Triton X-100 (PBT-X), for 48 h at 4 °C with 
gentle agitation. After washing, sections were incubated overnight at room 
temperature in biotinylated donkey anti-goat IgG (1:1000; Jackson 
Immunoresearch Laboratories, West Grove, PA) diluted in 2% NHS PBT-X. 
Sections were then incubated for 2h at room temperature in ABC reagent (Vector 
Elite kit: 6 μl/ml avidin and 6 μl/ml biotin; Vector Laboratories, Burlingame, CA). 
Black immunoreactive cytoplasm labeled for ChAT was revealed by a nickel-
intensified diaminobenzidine reaction, with peroxide being generated by glucose 
oxidase. First, sections were washed in PB, followed by 0.1 M acetate buffer, and 
then incubated for 15 min in 0.1 M acetate buffer (pH 6.0) containing 2% nickel 
sulfate, 0.0025% 3,3-diaminobenzidine, 0.004% ammonium chloride, and 0.02% 
d-glucose. The peroxidase reaction was started by adding glucose oxidase (0.2 
μl/ml) and stopped using acetate buffer (pH 6.0). Brain sections were then 
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washed in PB. Sections were mounted onto chrome-alum/gelatin-treated slides, 
dehydrated, cleared in histolene, and coverslipped with DePeX. 
A series of sections through the basal forebrain of lesioned and control mice was 
used to immunohistochemically label parvalbumin. Free-floating sections were 
washed repeatedly in PBS, followed by a 2h incubation in PBS containing 10% 
NHS and 0.5% Triton X-100. Mouse anti-parvalbumin (1:1000; Millipore, 
Temecula, CA), diluted in 0.1 M PBS containing 0.1% sodium azide, 2% NHS 
and 0.2% Triton X-100, was then added to the sections, which were incubated for 
48 h at room temperature, with gentle agitation. After washing, sections were 
incubated for 4 h at room temperature in donkey anti-mouse FITC (1:200; 
Jackson Immunoresearch Laboratories), diluted in 2% NHS PBT-X. After 
washing, sections were mounted onto chrome alum/gelatin-treated slides and 
coverslipped with buffered glycerol (pH 8.6). 
2.9 Neuronal counting 
Bilateral counts of neurons immunoreactive for ChAT were conducted through 
the rostro-caudal extent of the basal forebrain beginning 1.42 mm from Bregma 
(Franklin and Paxinos, 2007). Sections were 120 μm apart, with five sections 
being counted for the medial septum, four for the vertical diagonal band of Broca 
(beginning at section 3 of the medial septum) and five for the horizontal diagonal 
band of Broca (beginning at the end of the vertical diagonal band of Broca) by a 
researcher blind to the experimental conditions. 
Counts of parvalbumin-positive (p75NTR-negative) neurons were analyzed as 
above using images of sections of mu-p75-saporin and Rb-IgG-saporin injected 
brains. Eight-bit monochrome images were taken of the basal forebrain sections 
beginning 1.42 mm from Bregma. Images were captured using a Zeiss Axio 
Imager Z1 and AxioVision v4.8 software, before being exported into ImageJ 
software (NIH) where bilateral counts of parvalbumin-positive nuclei were 
conducted by a researcher blind to the conditions. 
Differences in the mean number of ChAT-immunoreactive and parvalbumin-
immunoreactive cells counted for each region of the basal forebrain per animal 
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per group were analyzed using ANOVA. 
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3. Results 
3.1 Mu-p75-SAP induced specific lesion of the cholinergic basal forebrain 
To selectively ablate basal forebrain cholinergic neurons, mice were injected with 
saporin conjugated to either a p75NTR antibody (mu-p75-SAP), or to a rabbit IgG 
(Rb-IgG-SAP) as a control. Following MRI scans, the extent and specificity of the 
lesion was determined by immunohistological analysis of the medial septum and 
the vertical and horizontal diagonal bands of Broca (Figure 1). These regions 
contain approximately equal numbers of cholinergic neurons, which express 
p75NTR (Mufson et al., 1989), and non p75NTR -expressing GABAergic neurons 
(Wainer et al., 1985). Both neuronal populations provide input to the 
hippocampus through the fimbria/fornix. 
While no overt atrophy of the structure was appreciable, a significant loss of 
approximately 30% of ChAT-positive (cholinergic) cells in the medial septum, and 
the vertical and horizontal diagonal bands of Broca was observed in the lesioned 
animals (Figure 1A, 1C). We also observed a clear reduction in ChAT-positive 
terminal labeling in the hippocampus of the lesioned mice (Figure 1C), indicating 
that the septo-hippocampal cholinergic system was functionally impaired in these 
animals. 
To determine if the treatment caused a specific loss of the cholinergic cells in the 
basal forebrain we also quantified the number of GABAergic neurons, visualized 
by parvalbumin staining, in the medial septum, and the vertical and horizontal 
diagonal bands of Broca (Figure 1B; 1D). This analysis revealed no significant 
effect of mu-p75-SAP injections compared to Rb-IgG-SAP treatment on 
parvalbumin-positive neuron number (Figure 1B, 1D), indicating that we had 
achieved a specific lesion of basal forebrain cholinergic neurons. 
3.2 Increased diffusion in the basal forebrain inversely correlated to cholinergic 
neurodegeneration 
To determine whether the lesion could be detected by MRI measures, the basal 
forebrain diffusion MRI parameters for each of the brains were analyzed. Firstly, 
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individual basal forebrain masks were created (Figure 2A; 2B, see section 2.3). 
These encompassed the medial septum and the vertical and horizontal diagonal 
bands of Broca (Figure 2C, D). The color-coded FA map in combination with the 
mouse brain atlas was used to create masks of the basal forebrain for each brain 
according to nearby landmarks. Given the lack of specific anatomical boundaries 
observable by MRI contrast, the masks by definition also contained minor parts 
of the lateral diagonal band of Broca (also called the magnocellular preoptic 
nucleus), as well as the basal part of the substantia innominata in the posterior 
section of the mask (ventral part of the mask in Figure 2E).  
Given the time between induction of the lesion and imaging, we did not expect or 
observe by histology overt atrophy of the basal forebrain. This was confirmed 
when we compared the size of the masks between groups, which revealed no 
significant difference in voxel number for control animal masks compared with 
the masks of lesioned animals (control: 882 ± 21 voxels; lesion: 902 ± 27 voxels; 
n = 4, mean ± SEM). Furthermore given the extent of the lesion, we did not 
expect atrophy of the hippocampus to occur, caused by the degeneration of 
cholinergic neurons. Comparison of normalized hippocampal volume between 
lesioned and control groups revealed no statistically significant difference 
(control: 25.00 ± 0.56; lesion: 25.04 ± 0.63, n = 4, mean ± SEM). 
We hypothesized that the altered tissue characteristics induced by the neuronal 
loss in lesioned animals would result in increased diffusivity in the affected area. 
Mean FA, mean diffusivity, axial diffusivity and radial diffusivity within the basal 
forebrain mask area were extracted for each mouse and group averages were 
calculated and compared for significant differences. This analysis revealed that 
all diffusion metrics were significantly increased for the basal forebrain area in 
the lesioned group compared to the control group. Specifically, the mean values 
for FA (Figure 3A), mean diffusivity (Figure 3B), axial diffusivity (Figure 3C) and 
radial diffusivity (Figure 3D) were all significantly higher in the lesioned animals. 
To determine the correlation between histological measures and dMRI-
associated changes in response to basal forebrain cholinergic neuron loss, we 
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performed nonparametric correlation of regression analysis of the ChAT-positive 
neuron numbers and diffusion parameters (Figure 3 E-H). This revealed that all 
diffusion measures were significantly inversely correlated to ChAT-positive 
neuron number (Figure 3 E-H), in particular the increase in FA (Figure 3E). This 
indicates that dMRI parameters such as FA, mean diffusivity, axial diffusivity and 
radial diffusivity are sensitive measures of neuronal lesions and reflect the 
degree of neurodegeneration. 
3.3 Tractography streamlines showed possible decreased integrity 
We next investigated whether a significant reduction in septo-hippocampal 
connectivity could be detected in the lesioned group of animals. In order to 
analyze the streamlines connecting the basal forebrain and hippocampus, whole 
brain tractograms of mice were created using MRtrix. The basal forebrain mask 
and a hippocampal mask (Figure 4A; see section 2.3) were then applied to the 
tractograms to delineate the streamlines between these two structures via the 
fimbria/fornix. The resulting streamlines (Figure 4 A-C) were anatomically verified 
(Figure 4D) as innervating the alveus and the oriens layer of the hippocampus 
and, to a lesser degree, other regions of the hippocampus such as the CA3 
region and the dentate gyrus (Cole and Nicoll, 1984).  
Having established a septo-hippocampal connection, we analyzed the septo-
hippocampal streamlines (Figure 5) in each mouse by comparing FA, mean 
diffusivity, axial diffusivity, and radial diffusivity, as well as track volume, 
streamline length and streamline number between the control and lesioned 
groups. This revealed an increase in radial diffusivity (p = 0.03, Figure 5C) and 
trend toward an increase in mean diffusivity (p = 0.06, Figure 5D) in the lesioned 
group, but neither measure was significantly different from the average of the 
control group following correction for multiple comparisons. No significant 
differences were observed in FA (Figure 5A) and axial diffusivity (Figure 5B), or 
in track volume, streamline length or normalized streamline number (Table 1). 
Finally, to control for the diffusion changes being selective for the basal forebrain 
tracts, we performed tractography analysis on a cerebellar tract (see section 2.4), 
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namely the inferior cerebellar peduncle (Figure 6A,B), which we reasoned should 
not be affected by either the application of mu-p75-SAP or the surgery. Our 
comparison revealed no differences in measures of streamline FA, axial 
diffusivity, radial diffusivity, or mean diffusivity (Figure 6C-F), nor in track volume, 
streamline length and streamline number (Table 2) of the inferior cerebellar 
peduncle. This indicated that the p75-directed toxin did not induce systemic 
axonal degeneration in the mouse brain but caused a specific lesion of basal 
forebrain cholinergic neurons, which could be detected by tractography of the 
septo-hippocampal streamlines. 
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4. Discussion 
In this study we used a robust animal model of specific cholinergic lesion of the 
septo-hippocampal system, mimicking the loss and denervation of basal 
forebrain cholinergic neurons observed in Alzheimer's disease (Rossner, 1997). 
We produced a ~30% reduction in this cholinergic pathway, which mimics mild 
pathology, and therefore possibly MCI or the prodromal stage of Alzheimer’s 
disease rather than severe late-stage loss of basal forebrain cholinergic neurons 
(Mufson et al., 2002). Despite the small number of experimental animals (n = 4 
per group) dMRI was able to detect this mild basal forebrain neurodegeneration. 
This minor change in total neuron number in the basal forebrain nuclei, was 
clearly identified on the high-resolution dMRI scans. A total of four diffusion 
parameters, FA, mean diffusivity, axial diffusivity and radial diffusivity, showed a 
significant increase within the basal forebrain area and all of these measures 
significantly inversely correlated to the basal forebrain cholinergic neuron count. 
As the FA parameter showed the greatest effect, we propose that this provides 
an extremely accurate and sensitive measure to determine the extent of tissue 
lesion prior to detection of volumetric changes. 
In general, increases in mean, axial and radial diffusivity are well-established 
features of neuronal degeneration (Filippi and Agosta, 2011). However it has 
been shown that neuronal degeneration usually results in a decrease of water 
anisotropy or FA in the affected regions (i.e. a less preferred direction of 
diffusion; Filippi and Agosta, 2011). In contrast we observed an increase in FA in 
the lesioned group compared to control. This can be explained by the direct 
relationship of the FA to the axonal/microscopic organization within a voxel. FA in 
the basal forebrain tissue reflects cell bodies and axons, innervating axons of 
posterior brain regions such as the pons, as well as axons from the locus 
coeruleus which also pass through the basal forebrain en route to the cortex 
(Sara, 2009). In this tissue, a proportion of the axons, including cholinergic axons, 
are crossing over other axons. Therefore the FA consists of multiple incoherent 
diffusion orientations. Once a significant number of basal forebrain cholinergic 
neurons and their axons have degenerated, due to lesioning, one diffusion 
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direction maybe selectively removed, and the tissue may therefore appear to 
have relatively higher directional diffusion along the remaining neuronal tracks, 
resulting in a higher FA in the lesioned group compared to the control. This 
phenomenon of increased FA in pathological conditions has been previously 
documented (Jones, 2010; Tuch et al., 2005) and highlights the fact that 
interpretation of diffusion parameters must be carried out with reference to the 
nature of the pathology and the composition of the tissue being examined.  
The present study also demonstrates that diffusion MR tractography has the 
potential to be an extremely sensitive measure of cholinergic degeneration. 
Probabilistic tractography measures of projections between the basal forebrain 
nuclei and the hippocampus via the fimbria/fornix showed promise in detecting 
changes in streamline characteristics induced by loss of cholinergic axons, 
revealing trends toward significant increases in streamline mean diffusivity and 
streamline radial diffusivity. A significant number of axonal tracts project through 
the fornix, of which the cholinergic axons that were affected by the lesion make 
up only a minor proportion, possibly 15%. Because of this, we were not surprised 
to observe no changes in measures such as FA, number of streamlines, track 
volume or streamline length. 
Of the factors that can influence diffusion anisotropy, intra-axonal organization 
appears to have the greatest influence (Pierpaoli et al., 1996). However, other 
features, such as the density of fiber and glial cell packing, degree of myelination, 
and individual fiber diameter, may also play a role (Melhem et al., 2002). We 
observed trends toward a significant increase in radial diffusivity and mean 
diffusivity, of which the change in radial diffusivity was significant before 
correcting for multiple comparisons. This suggests that subtle microscopic 
changes to a minor proportion of fiber tracts might be measured by tractography. 
The trend in the diffusion measures of the septo-hippocampal tracts in the 
lesioned compared to control animals is especially notable because the 
cholinergic fibers within this tract are not myelinated (Brauer et al., 2000; Gartner 
et al., 2001). Although axonal organization and packing may underpin the 
observed changes, the increase in the proportion of myelinated fibers within the 
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measured region may also have contributed to the trend towards an increase in 
mean diffusivity and axial diffusivity. Consistent with this idea, demyelination of 
the corpus callosum has been shown to result in decreased axial diffusivity with 
no change in radial diffusivity (Wu et al., 2007). In this study we used a high-
order tractography model to detect differences between groups; however the 
small animal numbers in each group limited the power of our analysis. 
Although the FA has been widely used as a measure to assess the integrity of 
brain connections (Kiuchi et al., 2009; Pievani et al., 2010; Teipel et al., 2010), 
we did not observe any trends toward significance in this parameter in our study. 
In these studies FA has been used to assess white matter integrity. However in 
our case, when measuring the septo-hippocampal tracts, the FA will mainly 
reflect myelinated axons rather than the unmyelinated cholinergic tracts. Hence 
we observed the highest trend toward significance in an increase of radial 
diffusivity, but no change in FA. Indeed the significant increase in radial diffusivity 
in the fornix in MCI and Alzheimer's disease patients compared to healthy 
controls found by Pievani et al. (2010) may have been caused by degeneration of 
the cholinergic axons. In addition, significant changes in the integrity of tracts 
originating in the basal forebrain have been observed in Alzheimer's disease 
patients using tract-based spatial statistics, where measures of tract integrity 
were determined based on the FA parameter (Teipel et al., 2010). However, as 
cholinergic fibers are not myelinated, we suggest that use of radial diffusivity 
measures rather than FA, using either tractography or tract-based spatial 
statistics analyses, may be the most sensitive parameter to discern cholinergic 
axonal degeneration in the fornix. 
In neurodegenerative conditions such as Alzheimer's disease, axonal dystrophy 
and retraction occur early and may be reversible (Burek and Oppenheim, 1996). 
In the current study, the death of cholinergic neurons was mediated through 
administration of the toxin mu-p75-SAP such that axonal degeneration occurred 
coincidental or subsequent to cell body loss. Our findings of trends toward 
significant changes to diffusion parameters in the septo-hippocampal streamlines 
nonetheless serve as proof of principle that a moderate loss of cholinergic fibers 
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within the fornix can result in changes to radial diffusion parameters, and thus 
early changes associated with neurodegeneration may be observable even if the 
cell bodies are not yet lost. We therefore conclude that tractography shows 
promising sensitivity as a diagnostic tool for detecting pathological changes in the 
neuronal integrity of this fiber tract in humans, although such extrapolation 
remains to be further validated. Nonetheless, a recent study indicates that 
volumetric measurement of the basal forebrain already has diagnostic value 
beyond hippocampal volume measurements (Grothe et al., 2011). dMRI methods 
may enable diagnosis of brain changes that occur as a prelude to or are a risk 
factor for Alzheimer's disease prior to structural changes and cognitive decline. 
This in turn could inform clinical treatment with acetylcholine esterase inhibitor 
drugs at a time at which they are likely to be most efficacious for patients. 
5. Conclusions 
Our study demonstrates that a ~30% loss of basal forebrain cholinergic neurons 
is highly correlated to the changes in water diffusion in the basal forebrain area. 
In addition, cholinergic neurodegeneration could be detected by analyzing 
diffusion parameters of the streamlines of the septo-hippocampal tracts in a 
mouse model. This is the first study, to our knowledge, to show the direct 
relationship between neuronal cell count, one of the most basic methods of 
measuring pathology, and diffusion MRI parameters in a disease scenario. This 
provides an important step forward in validating dMRI as a diagnostic imaging 
tool for the detection of subtle neurodegenerative events. Given that cholinergic 
basal forebrain degeneration is an early feature of Alzheimer’s disease, our 
findings demonstrate the potential feasibility of combining conventional dMRI with 
tractography as a non-invasive diagnostic tool to analyze both regional brain 
changes and variations in connectivity as a method to detect degeneration prior 
to detecting volumetric changes by structural MRI.  
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Figure captions 
 
Table 1. Septo-hippocampal connections remained unchanged for track volume, 
streamline length and normalized streamline number in lesioned animals. n = 4 
per group, mean ± SEM 
 
Table 2. The toxin showed no effect on track volume, streamline length and 
normalized streamline number of the inferior cerebellar peduncle for lesioned 
animals compared to control animals. n = 4 per group, mean ± SEM 
 
 Figure 1. Intracerebroventricular application of mu-p75-saporin produced a 
specific lesion of basal forebrain cholinergic neurons. A. Mean (± SEM) total 
number of ChAT-positive neurons in the basal forebrain following application of 
mu-p75-SAP (Lesion, n = 4) or Rb-IgG-SAP (Control, n = 4). A significant 
decrease in the number of ChAT-positive neurons was found following 
application of mu-p75-SAP. B. Mean (± SEM) number of parvalbumin-positive 
neurons in the basal forebrain following application of mu-p75-SAP (n = 4) or Rb-
IgG-SAP (n = 3). Application of mu-p75-SAP had no effect on the number of 
parvalbumin-positive neurons. C. Photomicrographs of ChAT-immunopositive 
neuronal cell bodies in the basal forebrain and ChAT-immunoreactive terminal 
fields in the hippocampus following application of Rb-IgG-SAP (left) and mu-p75-
SAP (right). D. Photomicrographs of parvalbumin-immunopositive neuronal cell 
bodies in the medial septum and vertical diagonal band of Broca following 
application of Rb-IgG-SAP (left) and mu-p75-SAP (right). Scale bar = 400µm. * 
p<0.05 
 
Figure 2. Basal forebrain mask encompassing the medial septum, and the 
vertical and horizontal diagonal bands of Broca. The position of the basal 
forebrain mask (red) in MRI space is shown in three planes: A. sagittal (midline), 
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B. horizontal (level of anterior commissure crossing the midline), and C-E. 
coronal sections through the extent of the basal forebrain depicting the mask at 
approximately 1.10 mm (C), 0.86 mm (D) and 0.50 mm (E) anterior to Bregma. 
The mask was used as a volume to extract diffusion parameters for the basal 
forebrain and as a seed region for tractography streamlines. 
 
Figure 3. The mean FA, mean diffusivity, axial diffusivity and radial diffusivity 
values of lesioned animals in the area of the basal forebrain mask inversely 
correlated to the cholinergic neuron number in the basal forebrain. A comparison 
of group means of diffusion parameters for lesioned and control animals revealed 
that A. FA (mean ± SEM), B. mean diffusivity (mean ± SEM), C. axial diffusivity 
(mean ± SEM) and D. radial diffusivity (mean ± SEM) values were significantly 
increased for the basal forebrain of lesioned compared to control animals. Linear 
regression analysis of ChAT-positive neuron number (x-axis) to the previously 
mentioned diffusion parameters (y-axis) of individual animals of mu-p75-SAP 
(lesion) and Rb-IgG-SAP (control) groups revealed a significant inverse 
correlation of E. FA, F. mean diffusivity, G. axial diffusivity, as well as H. radial 
diffusivity parameters with ChAT-positive neuron number. n = 4 per group, * 
p<0.05; unit for mean diffusivity, axial diffusivity and radial diffusivity is [10-4 
mm2/s]. 
 
Figure 4. Tractography streamlines connecting the basal forebrain and 
hippocampus. The basal forebrain mask shown in Figure 3 was used as a seed 
region to generate a streamline profile of the basal forebrain and further 
delineated to only measure septo-hippocampal connections (yellow), shown in 
sagittal (A), coronal (B) and horizontal (C) planes. To achieve this, a 
hippocampus waypoint ROI at the level of (a) as indicated by the dashed line, 
was applied. D. A slice through the streamline profile is shown to validate the 
regions of the highest fiber density. Most streamlines were found to pass through 
the alveus (alv) and the oriens layer of the hippocampus (or) which are known to 
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contain fimbria/fornix output from pyramidal neurons and the septal/diagonal 
band input to basal dendrites of pyramidal neurons, respectively. A very small 
proportion of streamlines were found to project to areas such as the cingulum, 
CA1-3 and other regions of the hippocampus. Additional abbreviations: cg, 
cingulum; cp, cerebellar peduncle; DG, dentate gyrus; fmj, forceps major of the 
corpus callosum; MoDG, molecular layer of the dentate gyrus. 
 
Figure 5.  Increased MD and RD of septo-hippocampal streamlines after lesion 
of the cholinergic basal forebrain. Diffusion parameters for the streamlines shown 
in Figure 4 were analyzed, revealing that FA (A) and axial diffusivity (B) 
parameters were not significantly different between control and lesioned animals, 
whereas radial diffusivity (C) and mean diffusivity (D) values showed trends 
toward a significant increase in the lesioned animals. n = 4 per group; unit for 
mean diffusivity, axial diffusivity and radial diffusivity is [10-4 mm2/s]. 
 
Figure 6. Tractography of the inferior cerebellar peduncle, a white matter tract 
that should not be affected by the toxin-induced lesion or the surgery itself, 
shown in MRI space in coronal (A) and horizontal (B) planes. No changes in 
control vs. lesioned animals were observed for FA (C), axial diffusivity (D), radial 
diffusivity (E) or mean diffusivity (F). n = 4 per group; unit for mean diffusivity, 
axial diffusivity and radial diffusivity is [10-4 mm2/s]. 
 
 
Parameter Control Lesion Significance (p 
value) 
Track volume 
(voxels) 
11055 ± 459 11115 ± 396 0.89 
Streamline length 
(mm) 
10.25 ± 0.09 10.12 ± 0.02 0.34 
Normalized 
streamline number 
1.30 ± 0.06 1.27 ± 0.08 0.69 
 
Table 1
Parameter Control Lesion Significance (p 
value) 
Track volume 
(voxels) 
21682 ± 430 19876 ± 1290 0.86 
Streamline length 
(mm) 
10.15 ± 0.23 10.12 ± 0.28 0.34 
Normalized 
streamline number 
117.25 ± 7.30 123.07 ± 7.30 0.69 
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